
Master of Clinical Research and Product Development (MCRPD)
Since 2023, the HKSAR Government has initiated plans to develop Hong Kong into a Health and Medical Innovation Hub. One of the initiatives is the establishment of the Hong Kong Centre for Medical Products Regulation (CMPR), which is targeted to operate by the end of 2026. Once established, Hong Kong will be able to independently approve new medical products through its own regulatory system, reducing reliance on overseas approvals. This important development is expected to accelerate access to innovative medical treatments and stimulate growth in medical research and development across Hong Kong, the Greater Bay Area (GBA), and neighbouring regions.
MCRPD is an interdisciplinary programme (with 1-year full-time and 2-year part-time options) designed to equip students with the professional knowledge and practical skills required to meet the increasing demand for talent in drug and medical device registration, clinical research management, and healthcare product development.


Quick Facts
Mode of Study
1 year (full-time) / 2 years (part-time)
Medium of Teaching
English
Class Schedule
Weekday afternoon, evenings and occasionally Saturdays
Class Venue
HKU Main Campus, HKUMed Campus and/or Queen Mary Hospital
Class Format
Most classes are held in person (with occasional hybrid/online lectures)
Tuition Fee
1 year (FT): HK $290,000 / 2 years (PT): HK $270,000

"Why MCRPD"?

"Why HKU"?
QS World University Ranking 2027
2nd in Asia
11th in the World
37th Ranking by Subject (Medicine)
Times Higher Education Ranking 2026
6th in Asia
33th in the World
18th Ranking by Subject (Medical and Health)


Programme Leadership Team



Prof. Walter WK Seto
Programme Director
Prof. Desmond Yap
Co-Programme Director
Prof. George Leung
Co-Programme Director